Amagasaki-city, Japan Clinical Trials

A listing of Amagasaki-city, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 55 clinical trials
Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan

The purpose of this prospective, epidemiological, cohort study is to evaluate the lung microbiome in stable-state chronic obstructive pulmonary disease (COPD) in Japanese participants

dyspnea
spirometry
cough
corticosteroids
bronchodilator
GSK Investigational Site
 (6.1 away) Contact site
  • 1 views
  • 01 Aug, 2021
  • +9 other locations
GORE VIABAHN Endoprosthesis Post-Marketing Surveillance Study

This study will confirm the efficacy and safety in the clinical setting after the launch of the GORE VIABAHN stent graft (hereafter referred to as "Viabahn") for the treatment of patients with stenosis or occlusion at the venous anastomosis of synthetic arteriovenous access graft.

Osaka Vascular Access Temma Nakamura Clinic
 (6.8 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +16 other locations
A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

This study is a prospective, uncontrolled, central registration system, multicenter, domestic observational study (special drug-use surveillance) to evaluate the safety of 52-week clinical treatment with Beovu kit for intravitreal injection in nAMD patients.

Novartis Investigative Site
 (3.0 away) Contact site
  • 0 views
  • 29 Jul, 2021
  • +65 other locations
Special Drug Use-results Surveillance of Tabrecta Tablets

This study is an uncontrolled, primary data collection-based observational study to be conducted as a central registration system, multicenter special drug-use results surveillance. As an all-case study, this study will collect all patients treated with Tabrecta in a specified post-marketing period. The observation period of each patient is up to …

Novartis Investigative Site
 (3.0 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +12 other locations
Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients With Alcohol Dependence

The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol intake in the routine clinical setting in Japan.

Otsuka Pharmaceutical Co., Ltd.
 (6.1 away) Contact site
  • 0 views
  • 04 Mar, 2021
  • 1 location
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Objectives in this study is to compare the change of lung function after 24 months from baseline between the two groups; one is the patient group who decided to start biologics treatment, and another is the patient group who decided to start non-biologics treatment. The target patients are the adult …

Research Site
 (6.1 away) Contact site
  • 0 views
  • 15 Jul, 2021
  • +28 other locations
General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

To confirm and consider the occurrence of important identified risks described in the Japanese Pharmaceutical Risk Management Plan (J-RMP) under conditions used in routine medical practice. The safety specification include: uterine hypercontractions and associated foetal distress, uterine rupture, cervical laceration, amniotic fluid embolism, and foetal distress.

Osaka University Hospital (there may be other sites in this country)
 (8.9 away) Contact site
  • 0 views
  • 27 Apr, 2021
  • 1 location
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

This study is an uncontrolled, central registration system, open-label, multicenter observational study in patients using Kesimpta for the labeled indication.

Novartis Investigative Site
 (8.4 away) Contact site
  • 0 views
  • 15 Jul, 2021
  • 1 location
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

To collect and characterise the incidence of adverse events related to the safety specifications of the maintenance treatment after platinum-based chemotherapy in patients with BRCA mutated pancreatic cancer under the actual post-marketing use of LYNPAZA.

cancer chemotherapy
Research Site
 (6.1 away) Contact site
  • 0 views
  • 22 Jul, 2021
  • +18 other locations
ADYNOVATE Drug Use-Results Survey

The purpose of this survey is to understand the following items in the actual clinical use of ADYNOVATE in patients: Unexpected adverse drug reactions Occurrence of adverse drug reactions in the actual clinical use Factors that may affect safety and efficacy Occurrence of Factor VIII inhibitor development in patients with …

coagulation factor
factor viii inhibitor
adynovate
deficiency
antihemophilic factor
Osaka-City, Japan
 (4.9 away) Contact site
  • 132 views
  • 26 Jan, 2021
  • +48 other locations